Eslicarbazepine (Zebinix®)

Assessment Status Rapid review complete
Drug Eslicarbazepine
Brand Zebinix®
Indication For the treatment of Epilepsy
Assessment Process
Rapid review commissioned 01/08/2009
Rapid review outcome Full Pharmacoeconomic Evaluation Recommended

* Company did not submit, Eslicarbazepine (Zebinix®) was reimbursed under the Community Drugs Schemes following introduction of a Patient Access Scheme.